Showing 1 - 20 results of 27 for search 'Clint T. Allen', query time: 0.12s Refine Results
  1. 1
    Antigen processing and presentation in cancer immunotherapy

    Antigen processing and presentation in cancer immunotherapy by Maxwell Y Lee, Cem Sievers, Clint T Allen, Jun W Jeon

    Published 2020-10-01
    Get full text
    Article
  2. 2
    Trismus and voice change after starting tuberculosis treatment

    Trismus and voice change after starting tuberculosis treatment by Joseph M. Rocco, Dima A. Hammoud, Clint T. Allen, Frances Galindo, Elizabeth Laidlaw, Irini Sereti

    Published 2021-01-01
    Get full text
    Article
  3. 3
    ASTX660, an antagonist of cIAP1/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck cancer

    ASTX660, an antagonist of cIAP1/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck c... by Wenda Ye, Sreenivasulu Gunti, Clint T. Allen, Youji Hong, Paul E. Clavijo, Carter Van Waes, Nicole C. Schmitt

    Published 2020-01-01
    Get full text
    Article
  4. 4
    Preclinical study of a novel therapeutic vaccine for recurrent respiratory papillomatosis

    Preclinical study of a novel therapeutic vaccine for recurrent respiratory papillomatosis by Maxwell Y. Lee, Simon Metenou, Douglas E. Brough, Helen Sabzevari, Ke Bai, Caroline Jochems, Jeffrey Schlom, Clint T. Allen

    Published 2021-06-01
    Get full text
    Article
  5. 5
    Risk of recurrence after neoadjuvant chemotherapy and transoral robotic surgery in patients with oropharynx cancer that avoid adjuvant radiation

    Risk of recurrence after neoadjuvant chemotherapy and transoral robotic surgery in patients with oropharynx cancer that avoid adjuvant radiation by Alisha R. Pershad, Punam G. Thakkar, Joseph F. Goodman, Arjun Joshi, Seth M. Steinberg, Clint T. Allen, Charalampos S. Floudas

    Published 2024-04-01
    Get full text
    Article
  6. 6
    Antagonist of cIAP1/2 and XIAP enhances anti-tumor immunity when combined with radiation and PD-1 blockade in a syngeneic model of head and neck cancer

    Antagonist of cIAP1/2 and XIAP enhances anti-tumor immunity when combined with radiation and PD-1 blockade in a syngeneic model of head and neck cancer by Roy Xiao, Clint T. Allen, Linda Tran, Priya Patel, So-Jin Park, Zhong Chen, Carter Van Waes, Nicole C. Schmitt

    Published 2018-09-01
    Get full text
    Article
  7. 7
    HPV32‐related Heck’s disease in a chronic graft‐versus‐host disease patient with long‐term successful KTP laser treatment: A rare case report

    HPV32‐related Heck’s disease in a chronic graft‐versus‐host disease patient with long‐term successful KTP laser treatment: A rare case report by Joe Truong Nguyen, Clint T. Allen, Joshua T. Dodge, Koenraad Van Doorslaer, Alison A. McBride, Steven Z. Pavletic, Jacqueline W. Mays

    Published 2021-05-01
    Get full text
    Article
  8. 8
    Chordoma cancer stem cell subpopulation characterization may guide targeted immunotherapy approaches to reduce disease recurrence

    Chordoma cancer stem cell subpopulation characterization may guide targeted immunotherapy approaches to reduce disease recurrence by Diana C. Lopez, Diana C. Lopez, Kellsye P. Fabian, Kellsye P. Fabian, Michelle R. Padget, Michelle R. Padget, Yvette L. Robbins, Joshua T. Kowalczyk, Joshua T. Kowalczyk, Joshua T. Kowalczyk, Wiem Lassoued, Wiem Lassoued, Danielle M. Pastor, Danielle M. Pastor, Clint T. Allen, Clint T. Allen, Clint T. Allen, Gary L. Gallia, Gary L. Gallia, James L. Gulley, James L. Gulley, James W. Hodge, James W. Hodge, Nyall R. London, Nyall R. London, Nyall R. London

    Published 2024-04-01
    Get full text
    Article
  9. 9
    Alum-anchored IL-12 combined with cytotoxic chemotherapy and immune checkpoint blockade enhanced antitumor immune responses in head and neck cancer models

    Alum-anchored IL-12 combined with cytotoxic chemotherapy and immune checkpoint blockade enhanced antitumor immune responses in head and neck cancer models by James W Hodge, Howard Kaufman, Michelle R Padget, Kellsye P Fabian, Sailaja Battula, Wiem Lassoued, Ginette Santiago-Sanchez, Clint Tanner Allen

    Published 2024-10-01
    Get full text
    Article
  10. 10
    WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy

    WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy by Lillian Sun, Ellen Moore, Rose Berman, Paul E. Clavijo, Anthony Saleh, Zhong Chen, Carter Van Waes, John Davies, Jay Friedman, Clint T. Allen

    Published 2018-10-01
    Get full text
    Article
  11. 11
    Nanocomplex-based TP53 gene therapy promotes anti-tumor immunity through TP53- and STING-dependent mechanisms

    Nanocomplex-based TP53 gene therapy promotes anti-tumor immunity through TP53- and STING-dependent mechanisms by Ellen C. Moore, Lillian Sun, Paul E. Clavijo, Jay Friedman, Joe B. Harford, Anthony D. Saleh, Carter Van Waes, Esther H. Chang, Clint T. Allen

    Published 2018-07-01
    Get full text
    Article
  12. 12
    PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiation

    PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiation by Megan Morisada, Paul E. Clavijo, Ellen Moore, Lillian Sun, Michael Chamberlin, Carter Van Waes, James W. Hodge, James B. Mitchell, Jay Friedman, Clint T. Allen

    Published 2018-03-01
    Get full text
    Article
  13. 13
    Exploiting the immunogenic potential of standard of care radiation or cisplatin therapy in preclinical models of HPV-associated malignancies

    Exploiting the immunogenic potential of standard of care radiation or cisplatin therapy in preclinical models of HPV-associated malignancies by James W Hodge, Michelle R Padget, Kellsye P Fabian, Joshua T Kowalczyk, Diana C Lopez, Austin TK Hoke, Clint T Allen, Mario Hermsen, Nyall R London

    Published 2022-12-01
    Get full text
    Article
  14. 14
    Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials

    Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials by Ryuhei Okada, Aki Furusawa, Daniel W. Vermeer, Fuyuki Inagaki, Hiroaki Wakiyama, Takuya Kato, Tadanobu Nagaya, Peter L. Choyke, William C. Spanos, Clint T. Allen, Hisataka Kobayashi

    Published 2021-05-01
    Get full text
    Article
  15. 15
    Cure of syngeneic carcinomas with targeted IL-12 through obligate reprogramming of lymphoid and myeloid immunity

    Cure of syngeneic carcinomas with targeted IL-12 through obligate reprogramming of lymphoid and myeloid immunity by Youji Hong, Yvette Robbins, Xinping Yang, Wojciech K. Mydlarz, Anastasia Sowers, James B. Mitchell, James L. Gulley, Jeffrey Schlom, Sofia R. Gameiro, Cem Sievers, Clint T. Allen

    Published 2022-03-01
    Get full text
    Article
  16. 16
    PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations

    PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations by Jeffrey Schlom, James W Hodge, Clint T. Allen, Shahrooz Rabizadeh, Patrick Soon-Shiong, John H. Lee, Renee N. Donahue, Kristen Solocinski, Michelle R Padget, Kellsye P Fabian, Yvette Robbins

    Published 2020-05-01
    Get full text
    Article
  17. 17
    Oncogenic Ras and ΔNp63α cooperate to recruit immunosuppressive polymorphonuclear myeloid-derived suppressor cells in a mouse model of squamous cancer pathogenesis

    Oncogenic Ras and ΔNp63α cooperate to recruit immunosuppressive polymorphonuclear myeloid-derived suppressor cells in a mouse model of squamous cancer pathogenesis by Nozomi Sakakibara, Paúl E. Clavijo, Cem Sievers, Veronica C. Gray, Kathryn E. King, Andrea L. George, Roshini M. Ponnamperuma, Beatriz A. Walter, Zhong Chen, Carter Van Waes, Clint T. Allen, Wendy C. Weinberg

    Published 2023-08-01
    Get full text
    Article
  18. 18
    Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types

    Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types by Kristin C. Hicks, Massimo Fantini, Renee N. Donahue, Angie Schwab, Karin M. Knudson, Sarah R. Tritsch, Caroline Jochems, Paul E. Clavijo, Clint T. Allen, James W. Hodge, Kwong Y. Tsang, Jeffrey Schlom, Sofia R. Gameiro

    Published 2018-11-01
    Get full text
    Article
  19. 19
    Correction to: Augmentation of tumor expression of HLADR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses

    Correction to: Augmentation of tumor expression of HLADR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses by Riley M. Larkin, Diana C. Lopez, Yvette L. Robbins, Wiem Lassoued, Kenneth Canubas, Andrew Warner, Baktiar Karim, Ksenia Vulikh, James W. Hodge, Charalampos S. Floudas, James L. Gulley, Gary L. Gallia, Clint T. Allen, Nyall R. London

    Published 2024-09-01
    Get full text
    Article
  20. 20
    Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses

    Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses by Riley M. Larkin, Diana C. Lopez, Yvette L. Robbins, Wiem Lassoued, Kenneth Canubas, Andrew Warner, Baktiar Karim, Ksenia Vulikh, James W. Hodge, Charalampos S. Floudas, James L. Gulley, Gary L. Gallia, Clint T. Allen, Nyall R. London

    Published 2024-05-01
    Get full text
    Article

Search Tools: